Does warfarin prevent deep venous thrombosis in high-risk patients?

Journal of Family Practice

Volumn 53, Issue 3, 2004, Pages

  Spaulding, Rebecca L ^a   Chambliss, M Lee ^a   Mackler, Leslie ^b  

^a Moses Cone Health System ^*

^b MOSES CONE HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; WARFARIN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; HIGH RISK PATIENT; HUMAN; IMMOBILIZATION; LUNG EMBOLISM; REVIEW; SPINAL CORD INJURY; STROKE; TRAUMATOLOGY;

EID: 1542358038     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348:1425-1434.
2. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349:631-639.
3. Pinede L, Duhaut P, Cucherat M, Ninet J, Pasquier J, Boissel JP. Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials. J Intern Med 2000; 247:553-562.
4. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340:901-907.
5. Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 2001; 345:165-169.
6. Levine M, Hirsh J, Gent M, et al. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994; 343:886-889.
7. Rajan R, Gafni A, Levine M, Hirsh J, Gent M. Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation. J Clin Oncol 1995; 13:42-46.
8. Ginsberg JS, Bates SM, Oczkowski W, et al. Low-dose warfarin in rehabilitating stroke survivors. Thromb Res 2002; 107:287-290.
9. Hirsh J, Dalen J, Guyatt G; American College of Chest Physicians. The sixth (2000) ACCP guidelines for antithrombotic: therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest 2001; 119(1 Suppl):132S-193S.